Antares Pharma Inc. Daily Stock Analysis

Daily Stock Analysis, ATRS, Antares Pharma Inc, priceseries

Antares Pharma Inc. Daily Stock Analysis
Stock Information
Open
3.88
Close
3.86
High
3.99
Low
3.83
Previous Close
3.90
Daily Price Gain
-0.04
YTD High
3.99
YTD High Date
Mar 7, 2022
YTD Low
3.11
YTD Low Date
Jan 28, 2022
YTD Price Change
0.29
YTD Gain
8.12%
52 Week High
4.63
52 Week High Date
Jul 6, 2021
52 Week Low
3.11
52 Week Low Date
Jan 28, 2022
52 Week Price Change
-0.15
52 Week Gain
-3.74%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 13. 2017
2.49
Mar 21. 2017
2.67
6 Trading Days
7.16%
Link
LONG
Dec 12. 2017
1.86
Dec 29. 2017
2.00
12 Trading Days
7.35%
Link
LONG
Mar 5. 2018
2.29
Mar 15. 2018
2.49
8 Trading Days
8.69%
Link
LONG
Apr 10. 2018
2.20
Apr 20. 2018
2.32
8 Trading Days
5.40%
Link
LONG
Aug 16. 2018
3.30
Aug 29. 2018
3.51
9 Trading Days
6.22%
Link
LONG
Feb 22. 2019
3.22
Mar 8. 2019
3.62
10 Trading Days
12.45%
Link
LONG
Jun 24. 2019
3.02
Jul 11. 2019
3.25
12 Trading Days
7.58%
Link
LONG
Sep 10. 2019
3.35
Sep 26. 2019
3.55
12 Trading Days
5.83%
Link
LONG
Nov 11. 2019
3.77
Dec 9. 2019
4.68
19 Trading Days
24.12%
Link
LONG
Apr 6. 2020
2.27
May 5. 2020
2.96
20 Trading Days
30.51%
Link
LONG
Oct 1. 2020
2.84
Oct 20. 2020
3.19
13 Trading Days
12.41%
Link
LONG
Nov 27. 2020
3.12
Jan 5. 2021
3.80
25 Trading Days
21.86%
Link
LONG
Jan 7. 2021
3.95
Jan 28. 2021
4.39
14 Trading Days
11.22%
Link
LONG
Dec 17. 2021
3.30
Jan 4. 2022
3.52
11 Trading Days
6.59%
Link
Company Information
Stock Symbol
ATRS
Exchange
NasdaqCM
Company URL
http://www.antarespharma.com
Company Phone
609-359-3020
CEO
Robert F. Apple
Headquarters
New Jersey
Business Address
100 PRINCETON SOUTH, SUITE 300, EWING, NJ 08628
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001016169
About

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Description

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. In addition, the company is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes and osteoporosis; Makena QuickShot auto injectors for reducing risk of preterm birth; and VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency. It has strategic alliances and partnership arrangements with Teva Pharmaceutical Industries, Ltd.; AMAG Pharmaceuticals, Inc.; Ferring Pharmaceuticals Inc.; and Ferring B.V. The company was founded in 1979 and is headquartered in Ewing, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading